FIELD: medicine, in particular ophthalmology.
SUBSTANCE: treatment of ophthalmology diseases by administration in conjunctival sac of patient eye as well as injection of medicine, in particular alkali salt of 5-amino-2,3-dihydro-1,4-phtalasindione is disclosed. Eye drops, eye ointment contain alkali salts of 5-amino-2,3-dihydro-1,4-phtalasindione or mixture thereof, wherein lithium or sodium, or potassium, or calcium salt of 5-amino-2,3-dihydro-1,4-phtalasindione is selected as alkali salt, and mixture of above mentioned salt in equal ratio is used as mixture salts of 5-amino-2,3-dihydro-1,4-phtalasindione.
EFFECT: treatment method with improved effectiveness and reduced treatment duration.
16 cl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICINAL PREPARATION (VARIANTS) AND METHOD FOR ITS PRODUCING | 2003 |
|
RU2233161C1 |
| MEDICINAL PREPARATION (VARIANTS) | 2003 |
|
RU2302863C2 |
| MEDICINAL PREPARATION | 2003 |
|
RU2238730C1 |
| MEDICINAL PREPARATION (VARIANTS) AND METHOD FOR ITS PRODUCTION | 2001 |
|
RU2211036C2 |
| OINTMENT FOR TREATMENT OF AUTOIMMUNE DISEASES | 2003 |
|
RU2266118C2 |
| METHOD FOR PREPARING MEDICINAL PREPARATION | 2002 |
|
RU2222327C2 |
| INHALATION PREPARATION IN TREATMENT OF TUBERCULOSIS | 2003 |
|
RU2266119C2 |
| METHOD OF OBTAINING MEDICATION | 2010 |
|
RU2439063C1 |
| PHARMACEUTICAL COMPOSITION WITH IMMUNOMODULATORY, IMMUNOCORRECTING, IMMUNOSUPPRESSIVE, ANTIVIRAL, ANTI-INFLAMMATORY AND ONCOLYTIC ACTIVITIES | 2021 |
|
RU2775008C1 |
| MEDICINAL AGENT | 2000 |
|
RU2163122C1 |
